178 related articles for article (PubMed ID: 10198068)
1. Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching.
Joseph H; Gorska AE; Sohn P; Moses HL; Serra R
Mol Biol Cell; 1999 Apr; 10(4):1221-34. PubMed ID: 10198068
[TBL] [Abstract][Full Text] [Related]
2. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.
Gorska AE; Joseph H; Derynck R; Moses HL; Serra R
Cell Growth Differ; 1998 Mar; 9(3):229-38. PubMed ID: 9543389
[TBL] [Abstract][Full Text] [Related]
3. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis.
Serra R; Johnson M; Filvaroff EH; LaBorde J; Sheehan DM; Derynck R; Moses HL
J Cell Biol; 1997 Oct; 139(2):541-52. PubMed ID: 9334355
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta, c-Cbl, and PDGFR-alpha the in mammary stroma.
Crowley MR; Bowtell D; Serra R
Dev Biol; 2005 Mar; 279(1):58-72. PubMed ID: 15708558
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.
Gorska AE; Jensen RA; Shyr Y; Aakre ME; Bhowmick NA; Moses HL
Am J Pathol; 2003 Oct; 163(4):1539-49. PubMed ID: 14507660
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta signaling helps specify tumor type in DMBA and hormone-induced mammary cancers.
Crowley MR; Frost A; Chen DT; Baffi MO; Nicola T; Serra R
Differentiation; 2006 Feb; 74(1):40-52. PubMed ID: 16466399
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
Böttinger EP; Jakubczak JL; Haines DC; Bagnall K; Wakefield LM
Cancer Res; 1997 Dec; 57(24):5564-70. PubMed ID: 9407968
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.
Miettinen PJ; Ebner R; Lopez AR; Derynck R
J Cell Biol; 1994 Dec; 127(6 Pt 2):2021-36. PubMed ID: 7806579
[TBL] [Abstract][Full Text] [Related]
9. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway.
Bailey JP; Nieport KM; Herbst MP; Srivastava S; Serra RA; Horseman ND
Mol Endocrinol; 2004 May; 18(5):1171-84. PubMed ID: 14963111
[TBL] [Abstract][Full Text] [Related]
10. Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.
Roarty K; Baxley SE; Crowley MR; Frost AR; Serra R
Breast Cancer Res; 2009; 11(2):R19. PubMed ID: 19344510
[TBL] [Abstract][Full Text] [Related]
11. Epithelium-specific adenoviral transfer of a dominant-negative mutant TGF-beta type II receptor stimulates embryonic lung branching morphogenesis in culture and potentiates EGF and PDGF-AA.
Zhao J; Sime PJ; Bringas P; Gauldie J; Warburton D
Mech Dev; 1998 Mar; 72(1-2):89-100. PubMed ID: 9533955
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis.
Siegel PM; Shu W; Cardiff RD; Muller WJ; Massagué J
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8430-5. PubMed ID: 12808151
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution.
Bierie B; Gorska AE; Stover DG; Moses HL
J Cell Physiol; 2009 Apr; 219(1):57-68. PubMed ID: 19086032
[TBL] [Abstract][Full Text] [Related]
14. Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.
Maeda M; Shintani Y; Wheelock MJ; Johnson KR
J Biol Chem; 2006 Jan; 281(1):59-68. PubMed ID: 16267045
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of transforming growth factor-beta type II receptor stimulates embryonic mouse lung branching morphogenesis in culture.
Zhao J; Bu D; Lee M; Slavkin HC; Hall FL; Warburton D
Dev Biol; 1996 Nov; 180(1):242-57. PubMed ID: 8948588
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
[TBL] [Abstract][Full Text] [Related]
17. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.
Böttinger EP; Jakubczak JL; Roberts IS; Mumy M; Hemmati P; Bagnall K; Merlino G; Wakefield LM
EMBO J; 1997 May; 16(10):2621-33. PubMed ID: 9184209
[TBL] [Abstract][Full Text] [Related]
18. Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation.
Jhappan C; Geiser AG; Kordon EC; Bagheri D; Hennighausen L; Roberts AB; Smith GH; Merlino G
EMBO J; 1993 May; 12(5):1835-45. PubMed ID: 8491177
[TBL] [Abstract][Full Text] [Related]
19. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.
Piek E; Moustakas A; Kurisaki A; Heldin CH; ten Dijke P
J Cell Sci; 1999 Dec; 112 ( Pt 24)():4557-68. PubMed ID: 10574705
[TBL] [Abstract][Full Text] [Related]
20. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
